Our Model
Diversity, Equity, and Inclusion in Digitized Clinical Trials: Our Partners
The DiMe Diversity, Equity, and Inclusion in Digitized Clinical Trials project will develop the best practices necessary to harness the promise of digital transformation of clinical trials to benefit all individuals, not just the over-represented few.
Diversity of data is a critical factor for advancing healthcare; this will only be achieved through equitable practices that ensure more inclusivity of underrepresented and underserved populations, in all steps of the clinical trials process, including recruitment, conduct, and data analysis.
We are proud to bring together life science companies; diversity, equity, and inclusion experts; and other leaders from the health-tech continuum together in this pre-competitive environment to advance the field for all.
Diversity, Equity, and Inclusion in Digitized Clinical Trials: In The News
Digital medicine is the future. Build it with us.
DiMe’s projects are seeded by our member community, where experts share the greatest barriers to advancing the field of digital medicine. When the most complex and significant roadblocks can be addressed with a cross-ecosystem, pre-competitive approach, that’s where we come in: DiMe convenes multi-stakeholder teams to quickly dive deep into issues and rapidly produce high-quality resources that meaningfully enable progress.
Join DiMe and become a part of the growing community that is advancing the safe, effective, equitable, and ethical use of digital medicine to optimize human health.
